McKnight’s LTC News, March 6, 2026: …the agency (CMS) is undertaking a review “with the goal of supporting clinically indicated use while continuing to discourage inappropriate prescribing.”
CMS “REVIEWING” ITS POLICY ON ANTIPSYCHOTIC USE IN NURSING HOMES
